Early closing of hotels: Impacts on alcohol consumption, drunkenness, liver disease and injury mortality - Dunt DR, Jiang H, Room R.
INTRODUCTION: Early (six o'clock) closing of hotels was introduced in 1916 in Australia to curb heavy drinking. It lasted between 21 and 51 years in four Australian states. The aim of this study is to assess the impact of early closing on alcohol consumpti... (Source: SafetyLit)
Source: SafetyLit - December 8, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
NAFLD Familial Risk Score Tops FIB-4 Index for Finding Fibrosis NAFLD Familial Risk Score Tops FIB-4 Index for Finding Fibrosis
A new risk model for nonalcoholic fatty liver disease could offer a simpler and more accurate way of predicting advanced fibrosis in first-degree relatives.MDedge News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - December 8, 2023 Category: Primary Care Tags: Gastroenterology Source Type: news
MASLD Often Is Worse in Slim Patients MASLD Often Is Worse in Slim Patients
Among patients with metabolic dysfunction-associated steatotic liver disease, the rate of advanced fibrosis is more than twice as high in slim patients than in patients with overweight or obesity.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - December 7, 2023 Category: Gastroenterology Tags: Gastroenterology Source Type: news
Ultrasound model identifies NAFLD patients with advanced fibrosis
A model using ultrasonic biomarkers could help physicians identify patients with nonalcoholic fatty liver disease (NAFLD) who have advanced fibrosis, a study presented November 30 at the RSNA 2023 annual meeting found.
In his presentation, Katsutoshi Sugimoto, MD, PhD, from Tokyo Medical University in Japan discussed the performance of a model he and colleagues developed, which combines multiparametric ultrasound markers. They found that combining normalized local variance with shear-wave speed improves assessment of advanced liver fibrosis.
“The combination…improved the diagnostic performance of identifying [disease...
Source: AuntMinnie.com Headlines - December 6, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease
89bio Inc ETNB announced a successful end-of-Phase 2 Meeting with the FDA supporting the advancement of pegozafermin into Phase 3 in nonalcoholic steatohepatitis (NASH). The program will include two Phase 3 trials evaluating patients with NASH: • ENLIGHTEN-Cirrhosis trial will enroll patients with…#incetnb #fda #phase3 #enlightencirrhosis #f2f3 #ema #enlightenfibrosis #glp1 (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2023 Category: Consumer Health News Source Type: news
Tool Identifies Alcohol Relapse Risk After Liver Transplant Tool Identifies Alcohol Relapse Risk After Liver Transplant
A novel prognostic tool based on social determinants effectively predicted increased risk of alcohol use relapse in adults who underwent liver transplants for alcoholic liver disease.MDedge News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - December 1, 2023 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news
Polaris Group Announces First Patient Successfully Dosed with ADI-PEG 20/Placebo in Phase 2a Non-Alcoholic Steatohepatitis (NASH) Study
TAIPEI, Taiwan and SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Polaris Group (The Company, TWSE:6550), today announced that the first patient was successfully dosed in the Phase 2a clinical study for Non-Alcoholic Steatohepatitis (NASH). NASH, a progressive liver disease closely associated with…#taipei #taiwan #sandiego #polarisgroup #nash #adipeg20 #adipeg #howardchen #pegargiminase #bla (Source: Reuters: Health)
Source: Reuters: Health - November 30, 2023 Category: Consumer Health News Source Type: news
EXCLUSIVE: Ill, thin and broken, ex-England footballer Kieron Dyer, 44, was dying with a rare liver disease just 11 weeks ago. Now, he speaks for the first time after a 'miracle' transplant gave him a second shot at life
OLIVER HOLT: Kieron Dyer's version of A Christmas Carol has seen him get a second shot at life alongside wife, Holly, following a life-saving liver transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - November 27, 2023 Category: Consumer Health News Source Type: news
Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection
Elecsys ® HBeAg quant is an immunoassay that can be used as an early marker of acute hepatitis B infection, as well as an indicator of chronic active hepatitis in combination with other laboratory results and clinical information.The single test will inform clinicians if treatment is required and regimens are working in conjunction with other diagnostic assays.Almost 300 million people globally have chronic hepatitis B, causing a significant burden to health systems as it puts patients at high risk of death from cirrhosis and liver cancer.1Basel, 27 November 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the la...
Source: Roche Media News - November 27, 2023 Category: Pharmaceuticals Source Type: news
Patients with existing health issues are at a higher risk of sepsis, researchers say
The research found those from deprived communities and victims of health issues such as chronic liver disease and chronic kidney disease were more at risk of developing sepsis (Source: the Mail online | Health)
Source: the Mail online | Health - November 24, 2023 Category: Consumer Health News Source Type: news
Prevalence of NAFLD Set to Increase to 34.3 Percent in 2050
MONDAY, Nov. 20, 2023 -- The burden of nonalcoholic fatty liver disease (NAFLD) is predicted to continue increasing, according to a study presented at The Liver Meeting, the annual meeting of the American Association for the Study of Liver... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2023 Category: Pharmaceuticals Source Type: news
Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers
A single daily low dose of aspirin significantly reduced hepatic fat fraction and liver transaminase levels in a randomized trial in patients with metabolic-associated steatotic liver disease.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 16, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Experimental Weight-Loss Drug, Retatrutide, Slashed Fat in Livers of Obese People
WEDNESDAY, Nov. 15, 2023 -- Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows.
A wider study, published in June, found... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 15, 2023 Category: General Medicine Source Type: news
East Bay company's 'greatest biotech comeback' drives toward drug approval in rare liver disease
The company was forced in late 2019 to ice clinical trials of its lead drug in a rare, but severe liver disease; it now hopes to ask the FDA early next year to approve the drug. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 14, 2023 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
Ultrasound platform effective evaluating hepatic steatosis
Thursday, November 30 | 1:30 p.m.-1:40 p.m. | R6-SSGI19-1 | Room E352Attendees will hear about the potential for ultrasound-derived fat fraction to be an alternative tool for MRI in assessing hepatic steatosis.Yi Dong, MD, from Fudan University in Shanghai, China, will present findings that show how ultrasound-derived fat fraction can detect hepatic steatosis using MRI-derived proton density fat fraction as the reference standard.Several ultrasound platforms now provide quantitative measures of hepatic steatosis. One of these is ultrasound-derived fat fraction, which combines attenuation and backscatter quantification. ...
Source: AuntMinnie.com Headlines - November 14, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: 2023 Ultrasound Preview Source Type: news
